Research & Insights | Health ID

Explore the Future of Blood Collection Technology

Research

By Jacobson TA, Rahbari KJ, Schwartz WA, Bae Y, Zhang R, Nunes DA, Huang C, Issa RP, Smilowitz K, Yan LD, Hirschhorn LR, Khan SS, Huffman MD, Miller GE, Feinglass JM, McDade TW, Funk WE March 20, 2025
Dried blood spot sampling offers a scalable strategy to close diagnostic gaps and improve global surveillance for cardiovascular‐kidney‐metabolic syndrome. Dried blood spot assays have been developed for biomarkers that offer mechanistic insights including inflammatory and vascular injury markers.
By Isabela Ritter Ott, Debora Renata Macali Oliveira, Ana Paula Grando, Klaus Vogel Frohlich, Magda Susana Perassolo, Rafael Linden & Marina Venzon Antunes May 20, 2024
The study developed and validated a GC-NPD method for the quantification of topiramate (TPM) in capillary dried plasma spots (DPS) obtained using the HealthID PSD microsampling device. The method demonstrated good precision and accuracy, and TPM was shown to be stable in DPS stored at 4°C, 23°C, and 45°C for up to 21 d
By Amanda Pacheco Bondan & Rafael Linden June 23, 2023
This editorial discusses the intrinsic advantages of using plasma separation devices for capillary microsampling compared to dried blood spots (DBS), as well as the limitations of these devices in clinical settings.
By Gabriel Linden, Mariele Feiffer Charão & Rafael Linden June 10, 2023
The study validated the HealthID PSD microsampling device for measuring CHOL, HDL, TRIG, CRE, and HbA1c from capillary blood. The device enables passive plasma separation and accurate quantification using only five drops of blood. DPS extracts showed acceptable total error and strong agreement with conventional samples

Insights

July 2, 2025
A Health ID acaba de conquistar a aprovação da ANVISA para CINCO dispositivos próprios de coleta capilar!
May 28, 2025
O Brasil está prestes a dar um passo importante no cuidado com a saúde mental. O Projeto de Lei 387/25 propõe a inclusão de novos antidepressivos na lista de medicamentos essenciais do SUS, como escitalopram, sertralina e venlafaxina. Mas esse avanço levanta uma pergunta incômoda: quem vai garantir que esses tratamentos estão funcionando como deveriam?
By Eduardo Della Giustina February 17, 2025
Nos últimos anos, os avanços científicos colocaram a coleta de sangue capilar em destaque, validando sua eficácia e precisão para uma ampla gama de testes diagnósticos.
By Eduardo Della Giustina February 17, 2025
A ascensão dos testes laboratoriais domiciliares: como a coleta de sangue capilar está transformando o acesso aos cuidados de saúde.
By Grand Review Reserach September 19, 2024
The global dried blood spot collection cards market size is valued at USD 399.49 million in 2024.

Sign up for important updates and announcements.

Sign up and enjoy.

Contate-nos